Mar 27, 2026
Alan Armstrong- Amount
- $1,001 to $15,000
- Filed
- Jul 21, 2026
Congress ticker disclosure profile
As of August 4 at 8:00 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference FFIV. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
5
Disclosed ranges
$81K
Most active member desks
6 sells vs 5 buys
Latest trade Mar 27, 2026
Mar 27, 2026
Alan ArmstrongOct 22, 2025
Julie JohnsonOct 21, 2025
Julie JohnsonOct 21, 2025
Julie JohnsonNov 30, 2022
Dan SullivanMay 27, 2015
Thomas MacarthurJun 27, 2014
Lamar SmithJun 12, 2014
Lamar SmithJan 28, 2014
Lamar SmithJan 28, 2014
Lamar SmithJan 22, 2014
Lamar Smith| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong | Buy | $1,001 to $15,000 | Jul 21, 2026 | Open card |
| Oct 22, 2025 | Julie Johnson | Sell | $1,001 to $15,000 | Nov 14, 2025 | Open card |
| Oct 21, 2025 | Julie Johnson | Sell | $1,001 to $15,000 | Aug 5, 2026 | Open card |
| Oct 21, 2025 | Julie Johnson | Buy | $1,001 to $15,000 | Aug 5, 2026 | Open card |
| Nov 30, 2022 | Dan Sullivan | Sell | $1,001 to $15,000 | Jul 26, 2023 | Open card |
| May 27, 2015 | Thomas Macarthur | Sell | $1,001 to $15,000 | Jun 7, 2015 | Open card |
| Jun 27, 2014 | Lamar Smith | Sell | $1,001 to $15,000 | Aug 9, 2014 | Open card |
| Jun 12, 2014 | Lamar Smith | Sell | $1,001 to $15,000 | Jul 10, 2014 | Open card |
| Jan 28, 2014 | Lamar Smith | Buy | $976.95 | Jul 30, 2014 | Open card |
| Jan 28, 2014 | Lamar Smith | Buy | $1,001 to $15,000 | Feb 6, 2014 | Open card |
| Jan 22, 2014 | Lamar Smith | Buy | $1,001 to $15,000 | Feb 6, 2014 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 11 of 11 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.